Skip to main content
Top
Published in: Surgical Endoscopy 1/2014

01-01-2014

Response to glucose tolerance testing and solid high carbohydrate challenge: comparison between Roux-en-Y gastric bypass, vertical sleeve gastrectomy, and duodenal switch

Authors: Mitchell S. Roslin, Yuriy Dudiy, Andrew Brownlee, Joanne Weiskopf, Paresh Shah

Published in: Surgical Endoscopy | Issue 1/2014

Login to get access

Abstract

Background

Hyperinsulinemic hypoglycemia is common after Roux-en-Y gastric bypass (RYGB) and may result in weight regain. The purpose of our investigation was to compare the effect of RYGB, vertical sleeve gastrectomy (VSG), and duodenal switch (DS) on insulin and glucose response to carbohydrate challenge.

Methods

Patients meeting National Institutes of Health criteria for bariatric surgery selected their bariatric procedure after evaluation and education in this prospective nonrandomized study. Preoperatively and at 6, 9, and 12 months’ follow-up, patients underwent blood draw to determine levels of fasting glucose, fasting insulin, glycated hemoglobin (HbA1c), C-peptide, and 2-h oral glucose challenge test. Homoeostatic Model Assessment (HOMA)-IR, fasting to 1-h and 1- to 2-h ratios of glucose and insulin, were calculated. Statistical analysis was performed using ANOVA and Student’s paired t test. All procedures were performed via a laparoscopic technique at a single institution.

Results

Data from a total of 38 patients (13 RYGB, 12 VSG, 13 DS) were available for analysis. At baseline, all groups were similar; the only statistically significant difference was that DS patients had a higher preoperative weight and body mass index (BMI). All operations caused weight loss (BMI 47.7 ± 10–30.7 ± 6.4 kg/m2 in RYGB; 45.7 ± 8.5–31.1 ± 5.5 kg/m2 in VSG; 55.9 ± 11.4–27.5 ± 5.6 kg/m2 in DS), reduction of fasting glucose, and improved insulin sensitivity. RYGB patients had a rapid rise in glucose with an accompanying rise in 1-h insulin to a level that exceeded preoperative levels. This was followed by a rapid decrease in glucose level. In comparison, DS patients had a lower increase in glucose and 1-h insulin, and the lowest HbA1c. These differences were statistically significant at various data points. For VSG, the results were intermediary.

Conclusions

Compared to gastric bypass, DS results in greater weight loss and improves insulin sensitivity and glucose homeostasis without causing a hyperinsulinemic response. Because the response to challenge after VSG is intermediary, pyloric preservation alone cannot account for this difference.
Literature
1.
go back to reference Sjostrom L (2013) Review of the key results from the Swedish Obese Subjects (SOS) trial—a prospective controlled intervention study of bariatric surgery. J Intern Med 273(3):219–234PubMedCrossRef Sjostrom L (2013) Review of the key results from the Swedish Obese Subjects (SOS) trial—a prospective controlled intervention study of bariatric surgery. J Intern Med 273(3):219–234PubMedCrossRef
2.
go back to reference Cui Y, Elahi D, Andersen DK (2011) Advances in the etiology and management of hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass. J Gastrointest Surg 15(10):1879–1888PubMedCrossRef Cui Y, Elahi D, Andersen DK (2011) Advances in the etiology and management of hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass. J Gastrointest Surg 15(10):1879–1888PubMedCrossRef
3.
go back to reference Rabiee A, Magruder JT, Salas-Carrillo R, Carlson O, Egan JM, Askin FB, Elahi D, Andersen DK (2011) Hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: unraveling the role of gut hormonal and pancreatic endocrine dysfunction. J Surg Res 167(2):199–205PubMedCentralPubMedCrossRef Rabiee A, Magruder JT, Salas-Carrillo R, Carlson O, Egan JM, Askin FB, Elahi D, Andersen DK (2011) Hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: unraveling the role of gut hormonal and pancreatic endocrine dysfunction. J Surg Res 167(2):199–205PubMedCentralPubMedCrossRef
4.
go back to reference Roslin MS, Oren JH, Polan BN, Damani T, Brauner R, Shah PC (2013) Abnormal glucose tolerance testing after gastric bypass. Surg Obes Relat Dis 9(1):26–31PubMedCrossRef Roslin MS, Oren JH, Polan BN, Damani T, Brauner R, Shah PC (2013) Abnormal glucose tolerance testing after gastric bypass. Surg Obes Relat Dis 9(1):26–31PubMedCrossRef
5.
go back to reference Mathavan VK, Arregui M, Davis C, Singh K, Patel A, Meacham J (2010) Management of postgastric bypass noninsulinoma pancreatogenous hypoglycemia. Surg Endosc 24(10):2547–2555PubMedCrossRef Mathavan VK, Arregui M, Davis C, Singh K, Patel A, Meacham J (2010) Management of postgastric bypass noninsulinoma pancreatogenous hypoglycemia. Surg Endosc 24(10):2547–2555PubMedCrossRef
6.
go back to reference Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo-Clavell ML, Lloyd RV (2005) Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med 353(3):249–254PubMedCrossRef Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo-Clavell ML, Lloyd RV (2005) Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med 353(3):249–254PubMedCrossRef
8.
go back to reference Ajala O, English P, Pinkney J (2013) Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr 97(3):505–516PubMedCrossRef Ajala O, English P, Pinkney J (2013) Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr 97(3):505–516PubMedCrossRef
9.
go back to reference Halperin F, Patti ME, Skow M, Bajwa M, Goldfine AB (2011) Continuous glucose monitoring for evaluation of glycemic excursions after gastric bypass. J Obes 2011:869536PubMedCentralPubMedCrossRef Halperin F, Patti ME, Skow M, Bajwa M, Goldfine AB (2011) Continuous glucose monitoring for evaluation of glycemic excursions after gastric bypass. J Obes 2011:869536PubMedCentralPubMedCrossRef
10.
go back to reference Hedberg J, Sundbom M (2013) Superior weight loss and lower HbA1c 3 years after duodenal switch compared with Roux-en-Y gastric bypass—a randomized controlled trial. Surg Obes Relat Dis 8(3):338–343CrossRef Hedberg J, Sundbom M (2013) Superior weight loss and lower HbA1c 3 years after duodenal switch compared with Roux-en-Y gastric bypass—a randomized controlled trial. Surg Obes Relat Dis 8(3):338–343CrossRef
11.
go back to reference Rawlins L, Rawlins MP, Brown CC, Schumacher DL (2013) Sleeve gastrectomy: 5-year outcomes of a single institution. Surg Obes Relat Dis 9(1):21–25PubMedCrossRef Rawlins L, Rawlins MP, Brown CC, Schumacher DL (2013) Sleeve gastrectomy: 5-year outcomes of a single institution. Surg Obes Relat Dis 9(1):21–25PubMedCrossRef
12.
go back to reference Dorman RB, Rasmus NF, al-Haddad BJ, Serrot FJ, Slusarek BM, Sampson BK, Buchwald H, Leslie DB, Ikramuddin S (2012) Benefits and complications of the duodenal switch/biliopancreatic diversion compared to the Roux-en-Y gastric bypass. Surgery 152(4):758–765PubMedCrossRef Dorman RB, Rasmus NF, al-Haddad BJ, Serrot FJ, Slusarek BM, Sampson BK, Buchwald H, Leslie DB, Ikramuddin S (2012) Benefits and complications of the duodenal switch/biliopancreatic diversion compared to the Roux-en-Y gastric bypass. Surgery 152(4):758–765PubMedCrossRef
13.
go back to reference Salinari S, Bertuzzi A, Guidone C, Previti E, Rubino F, Mingrone G (2013) Insulin sensitivity and secretion changes after gastric bypass in normotolerant and diabetic obese subjects. Ann Surg 257(3):462–468PubMedCrossRef Salinari S, Bertuzzi A, Guidone C, Previti E, Rubino F, Mingrone G (2013) Insulin sensitivity and secretion changes after gastric bypass in normotolerant and diabetic obese subjects. Ann Surg 257(3):462–468PubMedCrossRef
14.
go back to reference McLaughlin T, Peck M, Holst J, Deacon C (2010) Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery. J Clin Endocrinol Metab 95(4):1851–1855PubMedCrossRef McLaughlin T, Peck M, Holst J, Deacon C (2010) Reversible hyperinsulinemic hypoglycemia after gastric bypass: a consequence of altered nutrient delivery. J Clin Endocrinol Metab 95(4):1851–1855PubMedCrossRef
15.
go back to reference Mallory GN, Macgregor AM, Rand CS (1996) The influence of dumping on weight loss after gastric restrictive surgery for morbid obesity. Obes Surg 6(6):474–478PubMedCrossRef Mallory GN, Macgregor AM, Rand CS (1996) The influence of dumping on weight loss after gastric restrictive surgery for morbid obesity. Obes Surg 6(6):474–478PubMedCrossRef
16.
go back to reference Frenken M, Cho EY, Karcz WK, Grueneberger J, Kuesters S (2011) Improvement of type 2 diabetes mellitus in obese and non-obese patients after the duodenal switch operation. J Obes 2011:860169PubMedCentralPubMedCrossRef Frenken M, Cho EY, Karcz WK, Grueneberger J, Kuesters S (2011) Improvement of type 2 diabetes mellitus in obese and non-obese patients after the duodenal switch operation. J Obes 2011:860169PubMedCentralPubMedCrossRef
17.
go back to reference Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, Thomas S, Abood B, Nissen SE, Bhatt DL (2012) Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 366(17):1567–1576PubMedCentralPubMedCrossRef Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, Thomas S, Abood B, Nissen SE, Bhatt DL (2012) Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 366(17):1567–1576PubMedCentralPubMedCrossRef
18.
go back to reference Mingrone G, Castagneto-Gissey L (2009) Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery. Diabetes Metab 35(6 Pt 2):518–523PubMedCrossRef Mingrone G, Castagneto-Gissey L (2009) Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery. Diabetes Metab 35(6 Pt 2):518–523PubMedCrossRef
19.
20.
go back to reference Johansson HE, Haenni A, Karlsson FA, Edén-Engström B, Ohrvall M, Sundbom M, Zethelius B (2010) Bileopancreatic diversion with duodenal switch lowers both early and late phases of glucose, insulin and proinsulin responses after meal. Obes Surg 20(5):549–558PubMedCrossRef Johansson HE, Haenni A, Karlsson FA, Edén-Engström B, Ohrvall M, Sundbom M, Zethelius B (2010) Bileopancreatic diversion with duodenal switch lowers both early and late phases of glucose, insulin and proinsulin responses after meal. Obes Surg 20(5):549–558PubMedCrossRef
Metadata
Title
Response to glucose tolerance testing and solid high carbohydrate challenge: comparison between Roux-en-Y gastric bypass, vertical sleeve gastrectomy, and duodenal switch
Authors
Mitchell S. Roslin
Yuriy Dudiy
Andrew Brownlee
Joanne Weiskopf
Paresh Shah
Publication date
01-01-2014
Publisher
Springer US
Published in
Surgical Endoscopy / Issue 1/2014
Print ISSN: 0930-2794
Electronic ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-013-3176-0

Other articles of this Issue 1/2014

Surgical Endoscopy 1/2014 Go to the issue